Global CRO Market 2015-2019

CRO(医薬品開発業務受託機関)の世界市場2015-2019

◆タイトル:Global CRO Market 2015-2019
◆商品コード:IRTNTR4915
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年12月31日
◆ページ数:75
◆資料形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥310,800見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD3,500 ⇒換算¥388,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、CRO(医薬品開発業務受託機関)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、CRO(医薬品開発業務受託機関)の世界市場規模及び予測、種類別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About CRO
Organizations that support outsourced research services for the Pharmaceutical, Biotechnology, and Medical Devices industries are called CROs. The nature of engagement of outsourced services is generally on contractual basis. This helps the vendors to control their R&D expenditure and concentrate on their core skills. CROs help vendors expand their capacities from clinical trials to healthcare regulatory submissions, biostatistics, and data management work. Furthermore, CROs have also started offering services at all phases (pre-clinical, phase I, phases II & IIIa, phases IIIb & IV, labs, and others) of drug development and discovery. CROs have built their capabilities from the earliest to the latest stages of drug development with emphasis on partnership, collaboration, and fee for service models.

TechNavio’s analysts forecast the Global CRO market to grow at a CAGR of 9.83 percent over the period 2014-2019.

[Covered in this Report]
The CRO market can be divided into two segments: Early-stage Development Services and Late-stage Development Services. To calculate the market size, the report considers the revenue generated from the sales of outsourcing of R&D services to CROs by global pharmaceutical and biopharmaceutical vendors.
TechNavio’s report, Global CRO Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global CRO market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Covance
• Parexel International
• PRA Health Sciences
• Quintiles Translational

[Market Driver]
• Increased Outsourcing of R&D Activities
• For a full, detailed list, view our report

[Market Challenge]
• Shortage of CRO Staff
• For a full, detailed list, view our report

[Market Trend]
• Increase in Number of M&A
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07.Market Segmentation by Type of Service
07.1 Global Early Stage Development Services Market
07.1.1 Market Size and Forecast
07.2 Global Late Stage Development Services Market
07.2.1 Market Size and Forecast

08.Market Segmentation by Therapeutic Area

09.Geographical Segmentation
09.1 CRO Market in Americas
09.1.1 CRO Market in the US
09.2 CRO Market in EMEA Region
09.3 CRO Market in APAC Region
09.3.1 CRO Market in China
09.3.2 CRO Market in India

10.Buying Criteria

11.Market Growth Drivers

12.Drivers and their Impact

13.Market Challenges

14.Impact of Drivers and Challenges

15.Market Trends

16.Trends and their Impact

17.Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.3 Other Prominent Vendors

18.Key Vendor Analysis
18.1 Covance Inc.
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2013
18.1.4 Product Portfolio by Revenue 2013
18.1.5 Business Segmentation by Revenue 2012 and 2013
18.1.6 Geographical Segmentation by Revenue 2013
18.1.7 Business Strategy
18.1.8 Recent Developments
18.1.9 SWOT Analysis
18.2 Quintiles Translational Corp.
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2013
18.2.4 Product Portfolio by Revenue 2013
18.2.5 Business Segmentation by Revenue 2012 and 2013
18.2.6 Geographical Segmentation by Revenue 2013
18.2.7 Business Strategy
18.2.8 Recent Developments
18.2.9 SWOT Analysis
18.3 Parexel International Corp.
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Product Portfolio by Revenue 2013
18.3.5 Business Segmentation by Revenue 2012 and 2013
18.3.6 Geographical Segmentation by Revenue 2013
18.3.7 Business Strategy
18.3.8 Recent Developments
18.3.9 SWOT Analysis
18.4 PRA Health Sciences Inc.
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Product Portfolio by Revenue 2013
18.4.5 Business Segmentation by Revenue 2012 and 2013
18.4.6 Geographical Segmentation by Revenue 2013
18.4.7 Business Strategy
18.4.8 Recent Developments
18.4.9 SWOT Analysis

19.Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: The Players in Clinical Research
Exhibit 3: Global CRO Market 2014-2019 (US$ billion)
Exhibit 4: Global CRO Market Segmentation by Type of Service
Exhibit 5: Global CRO Market Segmentation by Type of Service 2014
Exhibit 6: Global CRO Market Segmentation by Type of Activity 2014
Exhibit 7: Global Early Stage Development Services Market 2014-2019 (US$ billion)
Exhibit 8: Global Late Stage Development Services Market 2014-2019 (US$ billion)
Exhibit 9: Global CRO Market Segmentation by Type of Service 2014-2019 (US$ billion)
Exhibit 10: Global CRO Market Segmentation by Type of Service 2014-2019 (in Percent)
Exhibit 11: R&D Clinical Trial Pipeline by Therapeutic Area 2014
Exhibit 12: Global CRO Market by Geographical Segmentation 2014
Exhibit 13: Global CRO Market by Geographical Segmentation 2014-2019 (US$ billion)
Exhibit 14: Global CRO Market by Geographical Segmentation 2014-2019 (in Percent)
Exhibit 15: CRO Market in Americas 2014-2019 (US$ billion)
Exhibit 16: CRO Market in the US 2014-2019 (US$ billion)
Exhibit 17: CRO Market in EMEA Region 2014-2019 (US$ billion)
Exhibit 18: CRO Market in APAC Region 2014-2019 (US$ billion)
Exhibit 19: CRO Market in China 2014-2019 (US$ billion)
Exhibit 20: CRO Market in India 2014-2019 (US$ billion)
Exhibit 21: Research Cost Comparison in US and India
Exhibit 22: Number of Drugs Going Off-patent in 2013-2016
Exhibit 23: Key Factors in Failure of Clinical Trials
Exhibit 24: Strategic Alliances Between Large Biopharma Companies And CRO’s
Exhibit 25: Key Deals in the CRO and related services space
Exhibit 26: Global CRO Market by Vendor Segmentation 2014
Exhibit 27: Quintiles Market Sales by Segment 2013
Exhibit 28: Parexel International Segments
Exhibit 29: Percentage Market Share of Top 6 CRO’s
Exhibit 24: Covance Inc.: Business Segmentation by Revenue 2013
Exhibit 25: Covance Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: Covance Inc.: Sales by Geography 2013
Exhibit 24: Quintiles Translational Corp.: Business Segmentation by Revenue 2013
Exhibit 25: Quintiles Translational Corp.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: Quintiles Translational Corp.: Sales by Geography 2013
Exhibit 24: Parexel International Corp.: Business Segmentation by Revenue 2013
Exhibit 25: Parexel International Corp.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: Parexel International Corp.: Sales by Geography 2013
Exhibit 24: PRA Health Sciences Inc.: Business Segmentation by Revenue 2013
Exhibit 25: PRA Health Sciences Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: PRA Health Sciences Inc.: Sales by Geography 2013



【掲載企業】

Covance,Parexel International ,PRA Health Sciences ,Quintiles Translational,Increased Outsourcing of R&D Activities,For a full, detailed list, view our report

【資料のキーワード】

CRO(Contract Research Organization/医薬品開発業務受託機関)、アウトソーシング、代行サービス、研究開発、製薬、バイオ技術、医療機器、臨床試験

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[CRO(医薬品開発業務受託機関)の世界市場2015-2019] (Global CRO Market 2015-2019 / IRTNTR4915)販売に関する免責事項
[CRO(医薬品開発業務受託機関)の世界市場2015-2019] (Global CRO Market 2015-2019 / IRTNTR4915)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆